Dynatronics Corporation Participates in Canaccord Genuity 2020 Medical Technologies & Diagnostics Forum
Rhea-AI Summary
Dynatronics Corporation (NASDAQ:DYNT) participated in the Canaccord 2020 Medical Technologies & Diagnostics Forum on November 19, 2020. CEO John Krier and the leadership team updated investors on recent structural changes and future growth opportunities. Krier expressed excitement about sharing their story and the early results of their scalable business model. Investors can access the updated presentation on the company's investor relations website or request a copy directly from the investor relations team.
Positive
- Participation in Canaccord Forum enhances investor visibility.
- Emphasis on structural changes indicates proactive management strategies.
- Focus on scalable business model suggests potential for future growth.
Negative
- None.
News Market Reaction – DYNT
In the trading session that priced this news, DYNT gained 4.66%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EAGAN, MN / ACCESSWIRE / November 19, 2020 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation participated in the Canaccord 2020 Medical Technologies & Diagnostics Forum, that was held virtually today. John Krier, Chief Executive Officer and members of the Company's leadership team provided an update to investors including a discussion of recently announced structural changes and the Company's plans for pursuing future growth opportunities. All meetings were held in a 1-on-1 format.
"We were excited to participate in the Canaccord Forum to share our story and early results from our emerging, scalable business model," explained Krier.
Investors are encouraged to access our updated investor presentation on the investor relations portion of our website at https://irdirect.net/dynt or alternatively request a copy of the presentation from Peter Seltzberg or Skyler Black.
About Dynatronics Corporation
Dynatronics is a leading medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. The Company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The Company's products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin®, Solaris™, Hausmann™, Physician's Choice®, and PROTEAM™, among others. More information is available at www.dynatronics.com.
CONTACT:
Dynatronics Corporation
Investor Relations
Skyler Black
(801) 676-7201
skyler.black@dynatronics.com
Darrow Associates, Inc.
Peter Seltzberg, Managing Director
Investor Relations
(516) 419-9915
pseltzberg@darrowir.com
For additional information, please visit: www.dynatronics.com
Connect with Dynatronics on LinkedIn
SOURCE: Dynatronics Corporation
View source version on accesswire.com:
https://www.accesswire.com/617655/Dynatronics-Corporation-Participates-in-Canaccord-Genuity-2020-Medical-Technologies-Diagnostics-Forum